Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Ryan

Showing results (171-180 of 274) with videos related to

Pageof 28
Sort By:
The Oncologist|September 2, 2017
Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous NeoplasmsJoseph W Franses, Omer Basar, Abdurrahman Kadayifci, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
The Oncologist|February 23, 2013
Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancerMichael S Lee, Harvey J Mamon, Theodore S Hong, et al.
Advances in Radiation Oncology|July 26, 2017
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529Devarati Mitra, Theodore S Hong, Nora Horick, et al.
Plos One|August 31, 2017
Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survivalIlaria Pergolini, Vicente Morales-Oyarvide, Mari Mino-Kenudson, et al.
Cancer Chemotherapy and Pharmacology|October 15, 2013
Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinomaLipika Goyal, Jeffrey G Supko, Jordan Berlin, et al.
Cancer Discovery|October 4, 2015
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric CancerEunice L Kwak, Leanne G Ahronian, Giulia Siravegna, et al.
The Oncologist|October 14, 2018
Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous NeoplasmsJoseph W Franses, Omer Basar, Abdurrahman Kadayifci, et al.
Journal of the American College of Surgeons|February 2, 2023
Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat AnalysisZhi Ven Fong, Fidel Lopez Verdugo, Carlos Fernandez-Del Castillo, et al.
The Oncologist|October 31, 2018
Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Pageof 28

Showing results (171-180 of 274) with videos related to

Sort By:
Pageof 28
The Oncologist|September 2, 2017
Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous NeoplasmsJoseph W Franses, Omer Basar, Abdurrahman Kadayifci, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
The Oncologist|February 23, 2013
Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancerMichael S Lee, Harvey J Mamon, Theodore S Hong, et al.
Advances in Radiation Oncology|July 26, 2017
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529Devarati Mitra, Theodore S Hong, Nora Horick, et al.
Plos One|August 31, 2017
Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survivalIlaria Pergolini, Vicente Morales-Oyarvide, Mari Mino-Kenudson, et al.
Cancer Chemotherapy and Pharmacology|October 15, 2013
Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinomaLipika Goyal, Jeffrey G Supko, Jordan Berlin, et al.
Cancer Discovery|October 4, 2015
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric CancerEunice L Kwak, Leanne G Ahronian, Giulia Siravegna, et al.
The Oncologist|October 14, 2018
Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous NeoplasmsJoseph W Franses, Omer Basar, Abdurrahman Kadayifci, et al.
Journal of the American College of Surgeons|February 2, 2023
Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat AnalysisZhi Ven Fong, Fidel Lopez Verdugo, Carlos Fernandez-Del Castillo, et al.
The Oncologist|October 31, 2018
Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Pageof 28